Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
24
CDCTF Quote, Financials, Valuation and Earnings
Last price:
$12.72
Seasonality move
:
-3.74%
Day range:
$12.72 - $12.72
52-week range:
$12.72 - $12.72
Dividend yield:
4.25%
P/E ratio:
11.91x
P/S ratio:
2.17x
P/B ratio:
0.46x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$422.8M
Revenue:
$172.2M
EPS (TTM):
$1.07
Analysts' Opinion
-
Consensus RatingGoldcrest has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Goldcrest has an estimated downside of -- from its current price of $12.72.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $12.72.
Fair Value
-
According to the consensus of 0 analysts, Goldcrest has -- downside to fair value with a price target of -- per share.
CDCTF vs. S&P 500
-
Over the past 5 trading days, Goldcrest has underperformed the S&P 500 by -2.86% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Goldcrest does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Goldcrest has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Goldcrest reported revenues of $43.2M.
Earnings Growth
-
Goldcrest has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Goldcrest reported earnings per share of $0.22.
Enterprise value:
297.3M
EV / Invested capital:
--
Price / LTM sales:
2.17x
EV / EBIT:
5.72x
EV / Revenue:
1.53x
PEG ratio (5yr expected):
0.04x
EV / Free cash flow:
-2.95x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
5.72x
Gross Profit (TTM):
$94.4M
Return On Assets:
2.72%
Net Income Margin (TTM):
18.25%
Return On Equity:
2.79%
Return On Invested Capital:
2.91%
Operating Margin:
26.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $367M | $109.2M | $194.5M | $18.5M | $43.2M | |
| Gross Profit | $192.7M | $51.7M | $94.4M | $8.5M | $22.2M | |
| Operating Income | $152.8M | $11.5M | $51.6M | -$1.5M | $11.4M | |
| EBITDA | $154.7M | $13.2M | $51.9M | -$1.4M | $11.4M | |
| Diluted EPS | $2.89 | $0.29 | $1.07 | -$0.09 | $0.22 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $1.3B | $1.1B | $1.1B | $1.1B | |
| Total Assets | $1.7B | $1.7B | $1.3B | $1.3B | $1.4B | |
| Current Liabilities | $162.1M | $88.8M | $84.4M | $184.9M | $100.2M | |
| Total Liabilities | $599M | $584.3M | $426.1M | $397.9M | $441M | |
| Total Equity | $1.1B | $1.1B | $905M | $863.8M | $927.5M | |
| Total Debt | $506M | $468.3M | $338.3M | $326.8M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2009-03-31 | 2010-03-31 | 2011-03-31 | 2010-03-31 | 2011-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $223.8M | -$78.6M | $23.7M | -$9.1M | |
| Cash From Investing | -- | -$158.7K | $91.5M | $352.9K | -$5.9M | |
| Cash From Financing | -- | -$76.6M | -$315.5M | $2.3M | -$178.8M | |
| Free Cash Flow | -- | $222.9M | -$80.6M | $23.7M | -$11M | |
CDCTF
Sector
Market Cap
$422.8M
$1.1B
Price % of 52-Week High
100%
82.9%
Dividend Yield
4.25%
3.45%
Shareholder Yield
--
3.4%
1-Year Price Total Return
--
-4.55%
Beta (5-Year)
-0.058
0.881
Dividend yield:
4.25%
Annualized payout:
$0.53
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$12.72
200-day SMA
Sell
Level
$12.72
Bollinger Bands (100)
Sell
Level
12.72 - 12.72
Chaikin Money Flow
Sell
Level
-3.4K
20-day SMA
Sell
Level
$12.72
Relative Strength Index (RSI14)
Sell
Level
0.00
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$12.72
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-5.4K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.2753)
Buy
CA Score
(Annual)
Level (0.4837)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.9026)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Goldcrest Co Ltd is a property development company. It is engaged in the development and sale of condominiums in and around the Tokyo Metropolitan Area. The Company operates in three business segments such as Real Estate Sales, Real Estate Leasing, and Others. The Real Estate Sales segment deals with the development and marketing of condominiums such as Crest City, Crest Form series and Crest Residence. The Real Estate Leasing segment involves with office building and apartment leasing activities. The others segment offers real estate management services.
Stock Forecast FAQ
In the current month, CDCTF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CDCTF average analyst price target in the past 3 months is --.
-
Where Will Goldcrest Stock Be In 1 Year?
According to analysts, the consensus estimate is that Goldcrest share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Goldcrest?
Analysts are divided on their view about Goldcrest share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Goldcrest is a Sell and believe this share price will rise from its current level to --.
-
What Is Goldcrest's Price Target?
The price target for Goldcrest over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CDCTF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Goldcrest is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of CDCTF?
You can purchase shares of Goldcrest via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Goldcrest shares.
-
What Is The Goldcrest Share Price Today?
Goldcrest was last trading at $12.72 per share. This represents the most recent stock quote for Goldcrest. Yesterday, Goldcrest closed at $12.72 per share.
-
How To Buy Goldcrest Stock Online?
In order to purchase Goldcrest stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
